NAL has an option to purchase a company based in the Netherlands, that uses new and exciting technology to deliver vaccines against the flu and influenza viruses.
Ps I am looking at this as another BTA type investment, get in while the price is low..............watch it grow
ordinary and seasonal flu kills 500,000 people world wide, so a huge earner for the companies that can stall this appalling waste of lives
that company is called Bestewil Holdings Ltd, it has several giant pharmaceutical companies interested in, or funding the development of..........Virosome
Virosomes are a new method of delivering vaccines
novel antigens, adjuvants and delivery systems Liposomes, a lot of research done, highly efficacies in vaccines intrinsic features in the use of vaccines ........Significant progress for a novel antigen delivery system includes the use of haemagglutinin from influenza viruses into liposomes, and can induce humoral and cell mediated immunity to antigens......
Did some research on this today, articles I read talked about using an reconstituted influenza virus envelopes, for the efficient delivery system , to introduce the new vaccine into the body a good ref page is (with loads of articles) www.ncbi.nlm.nih.gov/entrez then go to 'pubmed' and search for 'virosome'
a very interesting subject cheers
NAL Price at posting:
0.0¢ Sentiment: None Disclosure: Not Held